Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Debt to Equity (2021 - 2025)

Precision Biosciences (DTIL) has disclosed Debt to Equity for 4 consecutive years, with $0.24 as the latest value for Q4 2025.

  • Quarterly Debt to Equity fell 38.64% to $0.24 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.24 through Dec 2025, down 38.64% year-over-year, with the annual reading at $0.24 for FY2025, 38.64% down from the prior year.
  • Debt to Equity for Q4 2025 was $0.24 at Precision Biosciences, down from $1.35 in the prior quarter.
  • The five-year high for Debt to Equity was $1.35 in Q3 2025, with the low at $0.02 in Q2 2021.
  • Average Debt to Equity over 4 years is $0.54, with a median of $0.45 recorded in 2025.
  • The sharpest move saw Debt to Equity crashed 66.69% in 2024, then skyrocketed 291.64% in 2025.
  • Over 4 years, Debt to Equity stood at $0.02 in 2021, then skyrocketed by 4812.06% to $1.19 in 2023, then crashed by 66.69% to $0.4 in 2024, then plummeted by 38.64% to $0.24 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.24, $1.35, and $0.66 for Q4 2025, Q3 2025, and Q2 2025 respectively.